Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents

Circulating tumor necrosis factor‐α levels in non‐alcoholic fatty liver disease: A systematic review and a meta‐analysis

(2021) Victoria Potoupni et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Evaluation of non-alcoholic fatty liver disease in patients with inflammatory bowel disease using controlled attenuation parameter technology: A Taiwanese retrospective cohort study

(2021) Hsu-Heng Yen et al.   PLoS One

The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease

(2021) Giulia Gibiino et al.   Nutrients

Sarcopenia is a new risk factor of non-alcoholic fatty liver disease in patients with inflammatory bowel disease

(2020) Min Kyu Kang et al.   DIGESTIVE DISEASES

Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Systematic review with meta-analysis: biologics and risk of infection or cancer in elderly patients with inflammatory bowel disease

(2020) Daniele Piovani et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement

(2020) Mohammed Eslam et al.   JOURNAL OF HEPATOLOGY

Extraintestinal Manifestations in Patients with Inflammatory Bowel Disease: Study Based on the ENEIDA Registry

(2020) Alicia Algaba et al.   DIGESTIVE DISEASES AND SCIENCES

Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

(2020) Austin Lin et al.   INFLAMMATORY BOWEL DISEASES

Nonalcoholic Fatty Liver Disease Is Common in IBD Patients However Progression to Hepatic Fibrosis by Noninvasive Markers Is Rare

(2020) Gabrielle Ritaccio et al.   DIGESTIVE DISEASES AND SCIENCES

Commentary: nonalcoholic or metabolic dysfunction-associated fatty liver disease? The epidemic of the 21st century in search of the most appropriate name

(2020) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Epidemiology, Pathogenesis, Diagnosis and Emerging Treatment of Nonalcoholic Fatty Liver Disease

(2020) Evangelia Makri et al.   ARCHIVES OF MEDICAL RESEARCH

Prevalence and risk factors of nonalcoholic fatty liver disease in patients with inflammatory bowel diseases: A cross-sectional and longitudinal analysis

(2020) Peter Hoffmann et al.   WORLD JOURNAL OF GASTROENTEROLOGY

MAdCAM-1/α4β7 Integrin-Mediated Lymphocyte/Endothelium Interactions Exacerbate Acute Immune-Mediated Hepatitis in Mice

(2020) Angela Schippers et al.   Cellular and Molecular Gastroenterology and Hepatology

Systematic Review With Meta-analysis: Epidemiology of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease

(2019) Zi-Yuan Zou et al.   INFLAMMATORY BOWEL DISEASES

Crohn’s Disease is Associated with an Increased Prevalence of Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study using Magnetic Resonance Proton Density Fat Fraction Mapping

(2019) Scott McHenry et al.   Clinical Gastroenterology and Hepatology

Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study

(2019) Fotios S. Fousekis et al.   BMC GASTROENTEROLOGY

The Role of Early Biologic Therapy in Inflammatory Bowel Disease

(2019) Dana Rachel Berg et al.   INFLAMMATORY BOWEL DISEASES

Apelin promotes hepatic fibrosis through ERK signaling in LX-2 cells

(2019) Ying Wang et al.   MOLECULAR AND CELLULAR BIOCHEMISTRY

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease

(2019) Karn Wijarnpreecha et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Ustekinumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2019) Bruce E. Sands et al.   NEW ENGLAND JOURNAL OF MEDICINE

Nonalcoholic fatty liver disease in patients with inflammatory bowel disease: Beyond the natural history

(2019) Salvatore Magrì et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Effects of inflammatory bowel disease treatment on the risk of nonalcoholic fatty liver disease

(2018) Kamolyut Lapumnuaypol et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

(2018) Johan Burisch et al.   GUT

Sarcopenic obesity

(2018) Stergios A. Polyzos et al.   Hormones-International Journal of Endocrinology and Metabolism

Screening for Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Diseases: A Cohort Study Using Transient Elastography

(2018) Chiara Saroli Palumbo et al.   INFLAMMATORY BOWEL DISEASES

IRGM Gene Variants Modify the Relationship Between Visceral Adipose Tissue and NAFLD in Patients With Crohn’s Disease

(2018) Tracey G Simon et al.   INFLAMMATORY BOWEL DISEASES

Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors

(2018) Mariabeatrice Principi et al.   INFLAMMATORY BOWEL DISEASES

Non-alcoholic fatty liver disease phenotypes in patients with inflammatory bowel disease

(2018) Alessandro Sartini et al.   Cell Death & Disease

The Role of Beta-7 Integrin and Carbonic Anhydrase IX in Predicting the Occurrence of de Novo Nonalcoholic Fatty Liver Disease in Liver Transplant Recipients

(2018) Carmen Ester et al.   Chirurgia

Obesity Is Independently Associated With Higher Annual Burden and Costs of Hospitalization in Patients With Inflammatory Bowel Diseases

(2018) Nghia H. Nguyen et al.   Clinical Gastroenterology and Hepatology

Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics

(2018) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Non-alcoholic fatty liver disease in underweight patients with inflammatory bowel disease: A case-control study

(2018) Lisa C. Adams et al.   PLoS One

Influence of gut microbiota on the development and progression of nonalcoholic steatohepatitis

(2017) Fabiana de Faria Ghetti et al.   EUROPEAN JOURNAL OF NUTRITION

Pivotal Role of TNF-α in the Development and Progression of Nonalcoholic Fatty Liver Disease in a Murine Model

(2017) Satomi Kakino et al.   HORMONE AND METABOLIC RESEARCH

Primary sclerosing cholangitis is protective against nonalcoholic fatty liver disease in inflammatory bowel disease

(2017) Dustin E. Bosch et al.   HUMAN PATHOLOGY

Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease

(2017) Kerri Glassner et al.   INFLAMMATORY BOWEL DISEASES

P323 Fatty liver assessment in inflammatory bowel disease patients using controlled attenuation parameter

(2017) D.V. Balaban et al.   Journal of Crohns & Colitis

Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management

(2017) Marcus Harbord et al.   Journal of Crohns & Colitis

β 7 -Integrin and MAdCAM-1 play opposing roles during the development of non-alcoholic steatohepatitis

(2017) Hannah K. Drescher et al.   JOURNAL OF HEPATOLOGY

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

The gut microbiota, bile acids and their correlation in primary sclerosing cholangitis associated with inflammatory bowel disease

(2017) J Torres et al.   United European Gastroenterology Journal

An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies

(2017) Sanminder Singh et al.   PLoS One

Author Correction: Lack of NLRP3-inflammasome leads to gut-liver axis derangement, gut dysbiosis and a worsened phenotype in a mouse model of NAFLD

(2017) Irene Pierantonelli et al.   Scientific Reports

Emerging and future therapies for nonalcoholic steatohepatitis in adults

(2016) Gesthimani Mintziori et al.   EXPERT OPINION ON PHARMACOTHERAPY

The safety of vedolizumab for ulcerative colitis and Crohn's disease

(2016) Jean-Frédéric Colombel et al.   GUT

Significance of non-alcoholic fatty liver disease in Crohn's disease: A retrospective cohort study

(2016) Shintaro Sagami et al.   HEPATOLOGY RESEARCH

Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease

(2016) Talat Bessissow et al.   INFLAMMATORY BOWEL DISEASES

PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes

(2016) Rosellina Margherita Mancina et al.   INFLAMMATORY BOWEL DISEASES

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

(2016) Fernando Gomollón et al.   Journal of Crohns & Colitis

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR])

(2016) Bruce E. Strober et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Hepatic manifestations of inflammatory bowel diseases

(2016) Sophie Restellini et al.   LIVER INTERNATIONAL

Epidemiology and natural history of non-alcoholic fatty liver disease

(2016) Yousef Fazel et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adipokines in nonalcoholic fatty liver disease

(2016) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

(2016) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis

(2016) Yaron Ilan et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Co-existence of non-alcoholic fatty liver disease and inflammatory bowel disease: A review article

(2016) Che-Yung Chao et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Shifts in oxidation states of cerium oxide nanoparticles detected inside intact hydrated cells and organelles

(2015) Craig J. Szymanski et al.   BIOMATERIALS

Metabolic Inflammation in Inflammatory Bowel Disease

(2015) Pedro Gonçalves et al.   INFLAMMATORY BOWEL DISEASES

Serum levels of adipocytokines in psoriasis patients receiving tumor necrosis factor-αinhibitors: results of a retrospective analysis

(2015) Anna Campanati et al.   INTERNATIONAL JOURNAL OF DERMATOLOGY

Leptin in nonalcoholic fatty liver disease: A narrative review

(2015) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis

(2015) Der-Yuan Chen et al.   ARTHRITIS RESEARCH & THERAPY

Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease

(2014) E. Gizard et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Intestinal permeability – a new target for disease prevention and therapy

(2014) Stephan C Bischoff et al.   BMC GASTROENTEROLOGY

Effects of Vedolizumab Induction Therapy for Patients With Crohn’s Disease in Whom Tumor Necrosis Factor Antagonist Treatment Failed

(2014) Bruce E. Sands et al.   GASTROENTEROLOGY

Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: An experimental study in the rabbit

(2014) Linda Vignozzi et al.   MOLECULAR AND CELLULAR ENDOCRINOLOGY

National trends and inpatient outcomes of inflammatory bowel disease patients with concomitant chronic liver disease

(2014) Douglas L. Nguyen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Perfil lipídico e uso de anti-TNF-α

(2014) Antonio Carlos Ferraz Filho et al.   Revista Brasileira De Reumatologia

Personalised treatment using serum drug levels of adalimumab in patients with rheumatoid arthritis: an evaluation of costs and effects

(2013) C L M Krieckaert et al.   ANNALS OF THE RHEUMATIC DISEASES

Subcutaneous Golimumab Maintains Clinical Response in Patients With Moderate-to-Severe Ulcerative Colitis

(2013) William J. Sandborn et al.   GASTROENTEROLOGY

Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease

(2013) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

(2013) Brian G. Feagan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Effect of TNF inhibitors on lipid profile in rheumatoid arthritis: a systematic review with meta-analysis

(2012) Claire Immediato Daïen et al.   ANNALS OF THE RHEUMATIC DISEASES

Risk factors of non-alcoholic fatty liver disease in patients with inflammatory bowel disease

(2012) Achuthan Sourianarayanane et al.   Journal of Crohns & Colitis

Hepatic Steatosis and Disease Activity in Subjects with Psoriatic Arthritis Receiving Tumor Necrosis Factor-  Blockers

(2012) M. N. D. Di MINNO et al.   JOURNAL OF RHEUMATOLOGY

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

(2012) Jorge Henao-Mejia et al.   NATURE

Dysbiosis driven by inflammasome deficiency exacerbates hepatic steatosis and governs rate of NAFLD progression

(2012) Natalie J. Wood   Nature Reviews Gastroenterology & Hepatology

Hepatobiliary disorders among naïve patients with ulcerative colitis in Upper Egypt

(2012) Khairy Hammam Morsy et al.   Arab Journal of Gastroenterology

Changing shape of disease: Nonalcoholic fatty liver disease in Crohnʼs disease—A case series and review of the literature

(2011) Christopher E. McGowan et al.   INFLAMMATORY BOWEL DISEASES

DSS induced colitis increases portal LPS levels and enhances hepatic inflammation and fibrogenesis in experimental NASH

(2011) Erwin Gäbele et al.   JOURNAL OF HEPATOLOGY

The NLRP3 Inflammasome Protects against Loss of Epithelial Integrity and Mortality during Experimental Colitis

(2010) Md. Hasan Zaki et al.   IMMUNITY

Liver diseases associated with anti-tumor necrosis factor-alpha (TNF-α) use for inflammatory bowel disease

(2010) Carla S. Coffin et al.   INFLAMMATORY BOWEL DISEASES

Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease 12

(2010) Millie D. Long et al.   INFLAMMATORY BOWEL DISEASES

NLRP3 inflammasome plays a key role in the regulation of intestinal homeostasis

(2010) Simon A. Hirota et al.   INFLAMMATORY BOWEL DISEASES

α4β7 integrin/MAdCAM-1 adhesion pathway is crucial for B cell migration into pancreatic lymph nodes in nonobese diabetic mice

(2010) Baohui Xu et al.   JOURNAL OF AUTOIMMUNITY

The Potential Adverse Role of Leptin Resistance in Nonalcoholic Fatty Liver Disease

(2010) Stergios A. Polyzos et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

The role of the gut microbiota in nonalcoholic fatty liver disease

(2010) Ahmed Abu-Shanab et al.   Nature Reviews Gastroenterology & Hepatology

Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?

(2010) M. Diamant et al.   Obesity Reviews

Systematic review and meta-analysis: Anti-tumor necrosis factor α therapy and cardiovascular events in rheumatoid arthritis

(2010) Cheryl Barnabe et al.   ARTHRITIS CARE & RESEARCH

Hepatoprotective effect of tumour necrosis factor   blockade in psoriatic arthritis: a cross-sectional study

(2009) M. Seitz et al.   ANNALS OF THE RHEUMATIC DISEASES

The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease

(2009) Stergios A. Polyzos et al.   DIABETES OBESITY & METABOLISM

Effects of tumor necrosis factor alpha inhibition with infliximab on lipid levels and insulin resistance in patients with inflammatory bowel disease

(2009) Ioannis E. Koutroubakis et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

Acute Liver Cell Damage in Patients With Anorexia Nervosa: A Possible Role of Starvation-Induced Hepatocyte Autophagy

(2008) Pierre–Emmanuel Rautou et al.   GASTROENTEROLOGY

Immunology of the gut and liver: a love/hate relationship

(2008) D H Adams et al.   GUT

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

(2008) Jacquelyn J. Maher et al.   HEPATOLOGY